<DOC>
	<DOCNO>NCT01523574</DOCNO>
	<brief_summary>Introduction : Oxaliplatin ( Ox ) frequently use platinum-based medication part many chemotherapy regimen treatment several gastrointestinal malignancy . One important limitation use induction acute chronic peripheral neuropathy ( PN ) . Previous study show vitamin E reduce incidence cisplatin-induced PN 50 % . In study , investigator aim determine vitamin E could also prevent Ox-induced acute PN</brief_summary>
	<brief_title>Vitamin E Oxaliplatin-induced Peripheral Neuropathy Prophylaxis</brief_title>
	<detailed_description>This prospective , phase II , randomize pilot study . Patients randomize 5 day start Ox receive either vitamin E 400 mg daily placebo , end Ox-based chemotherapy regimen . The investigator evaluate PN intensity use CTCAE version 3 specific Ox PN gradation scale . The investigator include patient colorectal gastric cancer schedule receive Ox-based chemotherapy . Both group receive calcium magnesium supplement oxaliplatin infusion .</detailed_description>
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin E</mesh_term>
	<mesh_term>Tocopherols</mesh_term>
	<mesh_term>Tocotrienols</mesh_term>
	<mesh_term>alpha-Tocopherol</mesh_term>
	<mesh_term>Calcium , Dietary</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Magnesium Sulfate</mesh_term>
	<criteria>ECOG Performance status 0 1 Older 18 year New diagnose colorectal gastric cancer Scheduled receive oxaliplatinbased regimen Excluded patient previous history PN symptomatic PN entry study Excluded patient receive chemotherapy regimen ( except isolate 5fluorouracil ) Patients currently receive gabapentin , carbamazepine , amitriptyline , amifostine multivitamin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>oxaliplatin</keyword>
	<keyword>vitamin e</keyword>
	<keyword>neuropathy</keyword>
	<keyword>peripheral</keyword>
	<keyword>prophylaxis</keyword>
</DOC>